Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction

International Journal of Cardiology

Volumn 78, Issue 2, 2001, Pages 115-119

  Roldán, Vanessa ^a   Marín, Francisco ^b   Fernández, Pascual ^b   Luján, Juan ^c   Martínez, Juan G ^b   Pineda, Javier ^b   Marco, Pascual ^b   Sogorb, Francisco ^b  

^a Hospital de San Vicente   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Acute coronary syndromes; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; STATISTICS, NONPARAMETRIC; THROMBOPLASTIN;

EID: 0035033162     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00471-X     Document Type: Article

References (27)

1. Acute coronary syndromes: Biology
2. Unstable angina pectoris
3. The pathophysiology of acute coronary syndromes
4. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
5. The structural biology of expression and function of tissue factor
6. Tissue factor: Then and now
7. Increased monocyte tissue factor expression in coronary disease
8. Tissue factor pathway inhibitor
9. Tissue factor pathway inhibitor (TFPI). An update
10. Effects on enalapril on tissue factor in patients with uncomplicated acute myocardial infarction
11. Tissue factor modulates thrombogenicity of human atherosclerotic plaques
12. Identification of active tissue factor in human coronary atheroma
13. Tissue-factor antigen and activity in human coronary atherosclerotic plaques
14. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age
15. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients
16. Increased plasma tissue factor levels in acute myocardial infarction
17. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina
18. Tissue factor in atherosclerosis
19. Tissue factor in the pathogenesis of atherosclerosis
20. Tissue factor in human coronary atherosclerotic plaques
21. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes
22. Comparison of plasma tissue factor levels in unstable and stable angina pectoris
23. Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study
24. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity
25. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
26. Von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction
27. Tissue plasminogen activator as prognostic factor in patients with myocardial infarction